Generics 151

Originals

Biosimilars

Medical devices

Nutraceuticals

Filters

Meropenem manufacturers

151 products found

Filters

Filters

Filters , active

Country of origin : Kazakshan

Clear all

151 products found

meropenem

Solution for injection 500 mg, 1000 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Unavailable markets
Vietnam , Iraq
Manufacturer #12438
It was founded in the 1940s. One of the company’s main aims is the production of antibiotics. however, the production currently covers other therapeutic areas, including a broad portfolio of prescription, non-prescription, veterinary medicines, and dietary supplements. It sells in various international markets.

Manufacturer usually replies in 5 days

meropenem

Powder for solution for injection/infusion 500 mg, 1 g

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP, Greece
Unavailable markets
Kosovo
Manufacturer #298

Manufacturer usually replies in 4 days

meropenem

Vials, injection 500 mg, 1 g

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Comments
DCP successful, RMS: PT
Manufacturer #422

A pharmaceutical manufacturer based in the EU that has been active in 100+ countries selling its products in Europe, North America, Africa, the Middle East, and Asia for 40+ years. Main therapeutic areas include CNS, cardiovascular medication, and anti-infectives. The company's production lines are EU GMP-compliant. Key production lines are Rx and OTC. The company owns 20+ branches in Europe, Africa, and Asia.

Manufacturer usually replies in 5 days

meropenem

Powder for solution for injection 500 mg, 1000 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Unavailable markets
Iraq , Serbia , United Arab Emirates
Available for
Licensing with supply, Distribution only
Manufacturer #15070

A pharmaceutical manufacturer based in the EU that is selling its products in EU, CIS, and Asia. Key production lines are Rx, OTC, medical devices, and nutraceuticals. The company's production lines are EU GMP-compliant.

Manufacturer usually replies in 8 days

meropenem

Powder for solution for injection/infusion 500 mg, 1000 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Available for
Distribution only
Comments
Ref: Meronem®
Manufacturer #10720

It is one of the oldest pharmaceutical companies specializing in generic mostly for the hospital segment. The key products offered are life-saving medicines, especially in the CNS and cardiovascular therapeutic group. The company follows and complies with the EU GMP requirements.

Manufacturer usually replies in 4 days

meropenem

Vials, injection 500 mg, 1000 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Manufacturer #17289
The company offers a group of product portfolios consisting of leading molecules for the treatment of conditions like Alimentary Tract and Metabolism, Anti-infectives, Blood and Blood Forming Organs, Cardiovascular systems, Central Nervous systems, and Respiratory systems. It works in the complete development of these drugs, from clinical studies until the launch to the market. These specialties will be marketed either under their own brands or through licenses.

Manufacturer usually replies in 8 days

meropenem

Solution for infusion 500 mg, 1 g, 2 g

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Unavailable markets
Estonia , Iraq , Latvia , Libya , Lithuania , Vietnam
Manufacturer #2346

Manufacturer usually replies in 7 days

meropenem

Solution for injection 500mg/vial, 1g/vial

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
FDA, EU GMP, ANVISA
Unavailable markets
Libya , United States , Vietnam , Iraq
Manufacturer #5601
A pharmaceutical manufacturer based in the EU that has been active in 100+ countries selling its products for 50+ years. Key production lines are Rx and nutraceuticals. The company's production lines are cGMP-compliant. Main therapeutic areas include anti-infectives. Main dosage forms include oral and injectables The company possesses 20+ production facilities.

Manufacturer usually replies in 6 days

meropenem

Solution for injection 0,5g, 1g

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Manufacturer #623

Manufacturer usually replies in 9 days

meropenem

Powder for solution for injection 5 mg, 1 g

Dossier type
CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Unavailable markets
Algeria , Angola , Bahrain , Bulgaria , Cameroon , Colombia , Egypt , Ghana , Iran , Iraq , Israel , Jordan , Kuwait , Lebanon , Libya , Lithuania , Morocco , Nigeria , Oman , Qatar , Saudi Arabia , Senegal , South Africa , Sudan , Syria , Tunisia , Ukraine , United Arab Emirates , Vietnam , Yemen
Manufacturer #686
A pharmaceutical manufacturer based in the EU that has been active in 100+ countries selling its products in Europe, CIS, North America, LATAM, Africa, and Asia for 30+ years. The key production line is Rx. Main therapeutic areas include antibiotics, neurology, and cardiovascular. The main dosage form is injectable. The company's production lines are GMP-compliant. The company possesses different production lines in the EU.

Manufacturer usually replies in 5 days

meropenem

Vials, injection 1 g

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Unavailable markets
Iraq , Vietnam
Manufacturer #9660
A pharmaceutical manufacturer based in Europe that has been active for 50+ years. The main therapeutic areas include antibiotics. The main dosage forms include solids, liquids, and injectables. The company's production lines are GMP-compliant.

Manufacturer usually replies in 11 days

meropenem

Powder for solution for injection/infusion 500 mg, 1000 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Unavailable markets
Georgia , Iraq , Serbia , Ukraine , Vietnam
Comments
Reference product: Merrem, Pfizer
Manufacturer #3436

A pharmaceutical manufacturer based in the EU that has been active in 70+ countries selling its products in Europe, the Middle East, LATAM, North America, Africa, and Asia for 60+ years. Key production lines are Rx, OTC, and nutraceuticals. The company's production lines are EU GMP-compliant. Main therapeutic areas include the cardiovascular system, CNS, and dermatology. Main dosage forms include solid, topical, and suppositories.

Manufacturer usually replies in 20 days

meropenem

Injection 500 mg, 1 g

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Manufacturer #30077

Manufacturer usually replies in nan days

meropenem

Vials, injection 500mg, 1g

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
Thailand
GMP approvals
PICS
Manufacturer #14397
A pharmaceutical manufacturer based in Asia that has been active in Asia and the Middle East for 40+ years. The company's production lines are EU GMP-compliant. Key production lines are Rx, OTC, and nutraceuticals. The main therapeutic area includes the cardiovascular system, CNS, and anti-infec'tives.

Manufacturer usually replies in 3 days

meropenem

Solution for injection 500mg, 1g, 2g

Dossier type
CTD
Dossier status
Ready to file
Country of origin
South Korea
GMP approvals
EU GMP
Manufacturer #13135
The company has become a respected global health care group. The company has great growth potential. They use DDS source technology and an excellent pipeline to secure long-term growth. They are focused on profitability in a highly competitive market with new drugs and niche buster product launch technology.

Manufacturer usually replies in 7 days

meropenem + sulbactam

Solution for injection 250 mg + 125 mg, 500 mg + 250 mg, 1 g + 500 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
EU GMP, WHO
Manufacturer #2303

Manufacturer usually replies in 7 days

meropenem

Solution for injection 500 mg, 1 g, 2 g

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
EU GMP, WHO
Manufacturer #2303

Manufacturer usually replies in 7 days

meropenem

Vials, lyophilized injection 500mg, 1000mg

Dossier type
CTD
Dossier status
Under development
Country of origin
Ukraine
GMP approvals
EU GMP
MAs for sale
Bosnia And Herzegovina , Ukraine
Manufacturer #16118
The pharmaceutical plant follows the European standard throughout the plant. The core belief of the plant is to make sure that the customer receives the best pharmaceutical benefits as well as the intended patient care services.

Manufacturer usually replies in 7 days

meropenem

Vials, injection 125 mg, 500 mg, 1 g

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
EU GMP
Available for
Licensing with supply, Distribution only
Manufacturer #18885

Manufacturer usually replies in 7 days

meropenem

Powder for solution for injection/infusion 500 mg, 1 g

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Registered in
Bulgaria , Cyprus , Iraq , Italy , Malaysia , Pakistan , Portugal , Ukraine , United Arab Emirates
Available for
Licensing with supply, Distribution only
Manufacturer #8924

Manufacturer usually replies in 9 days

Want to view all 151 products? Create your free account today!

Meropenem

Meropenem is a broad-spectrum antibiotic. It is used in the treatment of a variety of bacterial infections which include meningitis, intra-abdominal infection, pneumonia, sepsis, and anthrax. It is also prescribed to treat Complicated Skin and Skin Structure Infections in both adult & Paediatric Patients 3 Months Of Age And Older Only, Complicated Intra-Abdominal Infections in adults and Paediatric Patients, for Bacterial Meningitis in Paediatric patients 3 Months Of Age or Older Only. Meropenem is sold under the brand names Merrem, Acus, and Adipen among others. Sumitomo Pharmaceuticals Company filed the first patent of Meropenem in 1983. It was approved for sales in the USA by the FDA in 1996. Due to its efficacy can safety record, it has earned a place on the WHO's List of Essential Medicines, and it classified Meropenem as critically important for human medicine.

Dosage Forms & administration

Meropenem is sold as a powder for an injectable solution in 500 mg and 1g vials. It is administered through an injection into the vein. For treating Complicated Skin and related Structure Infections, it can be prescribed as a single agent therapy caused by Staphylococcus aureus, pyogenes, agalactiae, viridans group streptococci, Enterococcus faecalis, Pseudomonas aeruginosa, Escherichia coli, Proteus mirabilis, Bacteroides fragilis, and Peptostreptococcus species., the usual recommended adult dose is 500 mg given through an IV every 8 hours. For Complicated Intra-abdominal Infections, the dose is set at 1 g, given every 8 hours. In the treatment of Community-Acquired Pneumonia, the dose is 500 mg given every 8 hours and the course is given for less than 5 days.

The price of Meropenem

In the USA, the consumer pays USD41 for a supply of 10 powder for injections of intravenous powder for injection of 500 mg. the cost of this medicine is significantly lower in the developing world, in India, a 1g injection cost around USD15.

How does Meropenem work?

Meropenem’s bactericidal activity results from the inhibition of cell wall synthesis. Meropenem works by penetrating the cell wall of Gram-positive and Gram-negative bacteria to reach the penicillin-binding- proteins. It has the highest affinities are toward PBPs 2, 3, and 4 of Escherichia coli and Pseudomonas aeruginosa and other similar infectious bacteria.

Finding Meropenem Manufacturers and Suppliers

The best way to find and gain access to Meropenem manufacturers and Meropenem suppliers is to make through Pipelinepharma's global B2B online marketplace for medicines and other pharmaceuticals. Normally, finding trusted manufacturers and supplies of specific drugs like Meropenem can be a the time-consuming challenge, but with Pipelinepharma's simple search engine and network of proven partners, the whole process becomes a lot easier. All you need to do to get started is to make use of our integrated search engine and start looking for suppliers or manufacturers of Meropenem to work with. You can fine-tune your search results using various filters too, letting you search for Meropenem from specific countries.